# SeroCovid<19: Covid-19 Seroconversion in Tertiary Pediatric Patients

> **NCT04615000** · — · COMPLETED · sponsor: **University Hospital, Ghent** · enrollment: 362 (actual)

## Conditions studied

- Covid19
- Children, Only

## Interventions

- **DIAGNOSTIC_TEST:** SARS-CoV-2 serological assessment (IgG)

## Key facts

- **NCT ID:** NCT04615000
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-29
- **Primary completion:** 2021-11-01
- **Final completion:** 2021-11-01
- **Target enrollment:** 362 (ACTUAL)
- **Last updated:** 2022-07-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04615000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04615000, "SeroCovid<19: Covid-19 Seroconversion in Tertiary Pediatric Patients". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT04615000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*